Consensus Owens & Minor, Inc.

Equities

OMI

US6907321029

Market Closed - Nyse Other stock markets 04:00:01 2024-06-12 pm EDT			5-day change	1st Jan Change
16.91 ^USD	+0.24%		-3.37%	-12.25%

May. 24	Owens & Minor, Inc. Names Jennifer Stone as Executive Vice President & Chief Human Resources Officer, Effective June 3, 2024	CI
May. 15	Transcript : Owens & Minor, Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 02:20 PM

Evolution of the average Target Price on Owens & Minor, Inc.

Price target over the last 5 years

History of analyst recommendation changes

292fce6cdd3140340c4.0nCGsqEJhMYNcsP8G1XpEmj-Qqh45m2r-vVX_0dOI10.lwH_3pd_9Y86QousaRacehCPAJwWhQrSmI0WoH4GWTeXMtD39GjQjGZFhg~fb2050eea8a2e0691dc1bdf08fab3524

Analyst Recommendations on Owens & Minor, Inc.

Baird Adjusts Owens & Minor Price Target to $24 From $28, Maintains Neutral Rating	May. 06	MT
Owens & Minor Insider Sold Shares Worth $585,680, According to a Recent SEC Filing	May. 03	MT
Citigroup Adjusts Price Target on Owens & Minor to $28 From $24, Maintains Neutral Rating	Apr. 30	MT
Baird Raises Owens & Minor's Price Target to $28 From $24, Maintains Neutral Rating	Apr. 10	MT
Citigroup Adjusts Owens & Minor's Price Target to $24 From $23, Keeps Neutral Rating	Feb. 21	MT
UBS Adjusts Owens & Minor Price Target to $27 From $26, Maintains Buy Rating	Feb. 21	MT
Barclays Raises Price Target on Owens & Minor to $23 From $21, Maintains Equalweight Rating	Feb. 21	MT
Barclays Adjusts Owens & Minor's Price Target to $23 From $21, Keeps Equalweight Rating	Feb. 21	MT
UBS Cuts Owens & Minor Price Target to $26 From $28, Maintains Buy Rating	Jan. 29	MT
UBS Adjusts Owens & Minor Price Target to $28 From $22, Maintains Buy Rating	Dec. 08	MT
JPMorgan Adjusts Owens & Minor's Price Target to $19 From $21, Maintains Underweight Rating	Nov. 17	MT
Baird Adjusts Owens & Minor's Price Target to $18 From $21, Maintains Neutral Rating	23-10-24	MT
Credit Suisse Adjusts Owens & Minor's Price Target to $19 From $18, Keeps Neutral Rating	23-08-08	MT
Citigroup Adjusts Owens & Minor's Price Target to $23 From $17, Keeps Neutral Rating	23-05-08	MT
UBS Adjusts Owens & Minor Price Target to $24 From $22, Maintains Buy Rating	23-05-08	MT
Credit Suisse Lifts Owens & Minor's Price Target to $18 From $17 After Above-Consensus Q1 Earnings, Keeps Neutral Rating	23-05-08	MT
Baird Adjusts Owens & Minor Price Target to $21 From $18, Maintains Neutral Rating	23-05-08	MT
UBS Lowers Owens & Minor's Price Target to $22 From $25, Maintains Buy Rating	23-03-10	MT
Citigroup Adjusts Price Target on Owens & Minor to $17 From $20, Maintains Neutral Rating	23-03-08	MT
Credit Suisse Lowers Owens & Minor's Price Target to $17 From $20 After Below-Consensus Q4 Earnings, 2023 Guidance; Keeps Neutral Rating	23-03-07	MT
UBS Adjusts Owens & Minor's Price Target to $25 From $23, Maintains Buy Rating	23-02-27	MT
Fitch Affirms Medline's Rating at 'B+'; Outlook Remains Negative	22-11-23	AQ
Citigroup Adjusts Price Target on Owens & Minor to $20 From $18, Maintains Neutral Rating	22-11-03	MT
UBS Lowers Owens & Minor's PT to $23 From $35, Keeps Buy Rating; Says Channel Checks Suggest H2 Products Segment Hit to Linger	22-10-31	MT
Credit Suisse Lowers Owens & Minor's PT to $20 from $37, Reducing Estimates on Disappointing Q3 Earnings Preview; Keeps Neutral Rating	22-10-14	MT